Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsNicole Mayer-Hamblett, Jessica Carey, Félix Ratjen et al.|The Lancet Respiratory Medicine|2022Cited by 128
Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and AdolescentsDaniel González, Michael Cohen‐Wolkowiez, John S. Bradley et al.|Antimicrobial Agents and Chemotherapy|2018Cited by 5
Reliability of Clinic-Obtained vs Self-Obtained Respiratory Samples From the Self-Sample Accuracy and Benefit Implementation Trial (S2wAB-IT)Jordana E. Hoppe, Christopher Siracusa, Marianne S. Muhlebach et al.|CHEST Journal|2026Cited by 1